Tag:
Complete Response Letter
Latest Headlines
Latest Headlines
FDA deals Merck two R&D setbacks with pair of CRLs
Merck ( $MRK ) has hit bumps in the road toward desired FDA approvals of its drugs MK-8175A, an oral contraceptive, and the ophthalmic drug tafluprost. The FDA sent the U.S. drug giant a pair of
